Kudla Cracks It

Why do young men get promoted on promise, while women have to prove themselves over and over? In this episode, we unpack the data behind one of the workplace’s most persistent double standards, the “potential vs. performance” bias. Drawing from McKinsey and LeanIn’s latest research, we explore how early-career promotions favor men, how bias shows up in performance reviews and leadership decisions,...

Cell therapy is one of the most promising frontiers in medicine — but scaling it remains a massive challenge. In this episode, we explore the complex landscape of cell therapy manufacturing, where automation is both a critical solution and a major stumbling block. From high capital costs and regulatory hurdles to the lack of interoperable systems and specialized talent, we break down why so few co...

Join me as I explore the unique and demanding challenges in pharmaceutical manufacturing , from stringent regulatory compliance and ensuring unwavering quality control to managing intricate global supply chains and integrating cutting-edge technologies. Discover why producing life-saving drugs is anything but simple

Tune in as we unravel the mysterious world of placebos and nocebos , exploring how your expectations can powerfully shape treatment outcomes, even with inert substances. We'll discuss their crucial role in double-blind clinical trials as the "gold standard" for validating treatments and delve into the complex ethical debates surrounding their use in both research and clinical practic...

Join us for a rapid dive into clinical trials , the "gold standard" of medical progress! These studies are fundamental to evaluating new treatments, generating crucial data on dosage, safety, and efficacy. We'll cover: The Phases : From Phase 0 (exploratory, first-in-human) to Phase I (safety, dosage in 20-80 people), Phase II (preliminary efficacy, 100-300 people), and Phase III (confirmation, la...

Unlock the secrets of drug approval ! This episode dives into the FDA's Abbreviated New Drug Application ( ANDA ) process, explaining how generic drugs are approved based on bioequivalence to provide safe, effective, and lower-cost alternatives. We also explore the innovative field of drug repurposing , where existing medications find new therapeutic uses, offering a streamlined path to treatm...

Explore the vital role of Contract Development and Manufacturing Organizations (CDMOs) in pharma. Learn how these partners offer end-to-end drug development and manufacturing services, from formulation to commercial production, providing specialized expertise, accelerating time-to-market, and ensuring regulatory compliance for pharmaceutical companies worldwide

We discuss the multifaceted nature of  beauty standards , exploring their historical evolution and  societal construction , often influenced by media and cultural narratives. examine the  psychological impact of these ideals , including links to body dissatisfaction, low self-esteem, and mental health issues, highlighting the significant financial and well-being costs incurred. address the concept...

Join us as we explore the journey of drug and medical device development . We'll cover preclinical research , focusing on initial safety and efficacy through lab and animal testing, and the challenges of predicting human outcomes. Then, we dive into clinical trials with human participants, navigating the distinct phases: Phase 0 & I : Small-scale studies for initial safety, dosage, and pha...

In this episode, we explore why pediatric oncology, despite urgent need and incredible scientific promise, continues to be overlooked by investors. We start with the reality check: a “therapeutic winter” where structural barriers and market hesitancy are starving innovation for children with cancer. Then we shift the lens, making the strategic case for why this isn’t just a moral imperative, but a...

Join us as we explore the dynamic world of biomarkers , measurable indicators of biological states crucial for modern medicine. Discover how these molecular, imaging, and physiological signals are revolutionizing patient care, from early disease detection and personalized treatment plans for conditions like cancer and Alzheimer's, to assessing risk in cardiovascular disease . We'll delve i...

Understanding Pharmacokinetics (PK) and Pharmacodynamics (PD) is crucial for effective drug development and patient care. This episode explores these two fundamental concepts: PK describes what the body does to the drug , covering its Absorption, Distribution, Metabolism, and Excretion (ADME) . Meanwhile, PD explains what the drug does to the body , focusing on its effects, mechanism of action , a...

This episode unpacks protein expression , the vital process where cells turn genetic information into functional proteins. Recombinant protein expression is crucial for modern biotechnology , enabling the production of proteins for everything from therapeutics and vaccines to structural studies. We'll cover common hurdles like low yields, misfolding, protein toxicity to host cells, and the need fo...

Bonus Epy! We define  a  Drug Mechanism of Action (MoA)  as the detailed  biochemical and molecular process  by which a drug produces its therapeutic effects. Explain how drugs interact with specific  molecular targets , such as  enzymes or receptors , to elicit  biological changes  within the body. Critical importance  of understanding MoA in various aspects of pharmacology, including  drug devel...

Bonus Epy! What excipients are and why they matter; their role in drug formulation, bioavailability, stability; regulatory considerations.

In this episode, we unpack the urgent challenges families face when navigating high-risk pediatric cancer, specifically neuroblastoma, and how emerging science in microbiome-based immunotherapy could change the game. We explore: What neuroblastoma is and why it’s so deadly for kids The multi-layered costs of accessing treatment, even experimental ones, still in trial How James Bitzer, a 5-year-old...

Bonus Epy! Active Pharmaceutical Ingredients (APIs) , the essential components in medications responsible for therapeutic effects. We cover: How APIs function in the body , interacting with biological targets to achieve desired outcomes, and  their global sourcing methods , highlighting the dominance of countries like India and China, alongside the use of in-house or outsourced manufacturing. Vari...

Join us for an insightful dive into the world of monoclonal antibodies (mAbs) , a groundbreaking class of therapeutic agents that are redefining how we treat diseases. From combating the global threat of shigellosis to transforming cancer care, these laboratory-produced proteins are mimicking our immune system's powerful ability to target and neutralize harmful invaders with remarkable precision....

Bonus Epy! AI in your Smart Home ....Unpacking Convenience, Privacy, and Ethical Dilemmas

Bonus Epy! Male Contraception: Debunking Myths, Unpacking Science, and Reshaping Reproductive Choice

Bonus Epy! Some basics you may or may not know about the pharma, biotech, CDMO, and Drug Dev Industry

Join us as we explore CRISPR-Cas9 , the revolutionary gene-editing technology often likened to molecular scissors or a programmable text editor for DNA . Discovered in a bacterial immune system, CRISPR allows scientists to precisely modify living organisms' genomes . This powerful tool is already making waves: In medicine , it's approved for sickle cell disease and beta thalassemia , showing promi...

Have you ever wondered about the hidden heroes of modern medicine? Join us as we delve into the fascinating, and sometimes controversial, world of cell lines, populations of cells that can be continuously grown and studied in the laboratory. These seemingly small entities have played an integral role in transforming scientific research and cell-based technologies , leading to countless breakthroug...

A comprehensive comparison between small molecules and biologics, two major categories of pharmaceutical drugs. Define each type based on its molecular structure, manufacturing processes, and administration methods, highlighting their distinct characteristics such as stability, cost, and complexity. Further examine the economic landscape of these drugs, including market share, growth trends, and t...

In this episode, we collectively explain the  rise of messenger RNA (mRNA) technology , particularly its accelerated development during the COVID-19 pandemic. Key factors contributing to its current prominence such as the  speed and flexibility of its design and manufacturing , and the  Nobel Prize-winning work  that overcame early immune rejection. Explore the  broader potential applications of m...